65.69
price up icon2.40%   1.54
after-market 시간 외 거래: 66.99 1.30 +1.98%
loading
전일 마감가:
$64.15
열려 있는:
$64.3
하루 거래량:
931.11K
Relative Volume:
0.83
시가총액:
$4.55B
수익:
$35.93M
순이익/손실:
$-244.56M
주가수익비율:
-16.63
EPS:
-3.95
순현금흐름:
$-157.31M
1주 성능:
+6.92%
1개월 성능:
+21.36%
6개월 성능:
+59.06%
1년 성능:
+20.09%
1일 변동 폭
Value
$64.27
$66.43
1주일 범위
Value
$61.33
$66.43
52주 변동 폭
Value
$33.19
$66.43

Merus N V Stock (MRUS) Company Profile

Name
명칭
Merus N V
Name
전화
31 030 253 8800
Name
주소
YALELAAN 62, 3584 CM UTRECHT
Name
직원
260
Name
트위터
@MerusNV
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
MRUS's Discussions on Twitter

MRUS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MRUS
Merus N V
65.69 4.78B 35.93M -244.56M -157.31M -3.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Merus N V Stock (MRUS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-13 개시 Piper Sandler Overweight
2025-02-07 개시 Wells Fargo Overweight
2024-11-21 개시 Goldman Buy
2024-10-24 개시 UBS Buy
2024-03-28 개시 Truist Buy
2024-03-04 재확인 Needham Buy
2023-11-02 개시 Canaccord Genuity Buy
2023-08-21 개시 TD Cowen Outperform
2022-08-02 개시 Stifel Buy
2022-02-11 개시 BMO Capital Markets Outperform
2022-02-10 개시 Needham Buy
2021-11-17 재개 Guggenheim Buy
2021-06-07 업그레이드 Citigroup Neutral → Buy
2021-04-08 개시 William Blair Outperform
2021-03-16 개시 SVB Leerink Outperform
2020-06-26 개시 H.C. Wainwright Buy
2020-05-27 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2019-11-20 재개 Guggenheim Buy
2019-06-28 개시 ROTH Capital Buy
2019-04-12 재개 Guggenheim Buy
2019-04-03 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2019-03-27 개시 Berenberg Buy
2018-01-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2017-09-15 개시 RBC Capital Mkts Outperform
2017-03-21 다운그레이드 Citigroup Buy → Neutral
2016-12-22 업그레이드 Citigroup Neutral → Buy
2016-11-07 다운그레이드 Citigroup Buy → Neutral
2016-06-13 개시 Citigroup Buy
2016-06-13 개시 Guggenheim Buy
2016-06-13 개시 Wedbush Outperform
모두보기

Merus N V 주식(MRUS)의 최신 뉴스

pulisher
Jul 23, 2025

What analysts say about Merus N.V. stockMarket-leading profit generation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Merus N.V. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Merus N.V. stock pricePhenomenal trading returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Merus N.V. a good long term investmentRapidly expanding wealth - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Merus Shares Soar 3.24% On Positive Cancer Study Update - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Merus NV stock hits all-time high, reaching 62.98 USD - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

Merus Shares Surge Amid Promising Cancer Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Merus N.V. Advances in Head and Neck Cancer Treatment with Phase 3 Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Learn to Evaluate (MRUS) using the Charts - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 17, 2025

Merus N.V. (NASDAQ:MRUS) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Merus N.V. (NASDAQ:MRUS) Given Average Rating of “Buy” by Analysts - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Why Merus N.V. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Merus N.V. stock performs during market volatilitySwing Trade Signals - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

Merus (MRUS) Gets a Buy from H.C. Wainwright - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Merus N.V. stock price move sharplyAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $924,275.00 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 12, 2025

Merus (NASDAQ:MRUS) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success - sharewise.com

Jul 11, 2025
pulisher
Jul 09, 2025

Merus, Bicara Present Promising HNSCC Trial Data at ASCO 2025, Advance Towards Phase III - Insider Monkey

Jul 09, 2025
pulisher
Jun 29, 2025

Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO-Backed Potential - AInvest

Jun 29, 2025
pulisher
Jun 26, 2025

Merus N.V.’s Promising Phase 3 Study in Head and Neck Cancer: What Investors Need to Know - TipRanks

Jun 26, 2025
pulisher
Jun 18, 2025

Merus gains after mid-stage trial data for lead asset in head and neck cancer - MSN

Jun 18, 2025
pulisher
Jun 15, 2025

(MRUS) Technical Data - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 14, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 11, 2025

Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus (NASDAQ:BCAX) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 10, 2025

The Netherlands: Merus raises US$300m from underwritten public offering - Investors in Healthcare

Jun 10, 2025
pulisher
Jun 08, 2025

Why Merus N.V. (MRUS) Crashed On Wednesday - MSN

Jun 08, 2025
pulisher
Jun 05, 2025

Merus N.V. announces proposed public offering of common shares - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus dips 7%, prices $300M stock at $57 per share - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus Announces Public Offering of Common Shares - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Merus Raises $300m After ASCO Success - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care Stocks Mixed Premarket Wednesday - marketscreener.com

Jun 04, 2025

Merus N V (MRUS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Merus N V 주식 (MRUS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Silverman Peter B.
COO & GC
Jul 17 '25
Sale
60.00
25,000
1,500,000
0
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):